 Clovis Oncology, Inc. NASDAQ: CLVS, Marker Therapeutics, Inc. NASDAQ: MRKR and Alector, Inc. NASDAQ: ALEC are among the biggest biotech gainers Friday. Clovis Jumps On Ovarian Cancer Data: Clovis announced positive results for the Phase 3 study of Rubraca in ovarian cancer. 